Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$0.4 - $0.9 $52 - $118
-132 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$0.72 - $1.54 $5 - $12
-8 Reduced 5.71%
132 $0
Q4 2021

Feb 23, 2022

SELL
$1.22 - $2.5 $2,458 - $5,037
-2,015 Reduced 93.5%
140 $0
Q3 2021

Oct 28, 2021

BUY
$2.73 - $4.52 $87 - $144
32 Added 1.51%
2,155 $6,000
Q2 2021

Aug 12, 2021

BUY
$2.74 - $4.63 $5,817 - $9,829
2,123 New
2,123 $7,000

About NeuroBo Pharmaceuticals, Inc.


  • Ticker NRBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 888,693
  • Market Cap $2.4M
  • Description
  • NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...
More about NRBO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.